Skip to main navigation Skip to search Skip to main content

Equivac® HeV vaccine for horses is cross protective against HeVg2 variant, as demonstrated by a recombinant Cedar Virus surrogate neutralisation assay.

Research output: Contribution to conferencePosterpeer-review

Original languageAmerican English
StateIn preparation - 2024
EventHendra@30 - Geelong, Australia
Duration: 8 Dec 202411 Dec 2024

Conference

ConferenceHendra@30
Country/TerritoryAustralia
CityGeelong
Period8/12/2411/12/24

Fingerprint

Dive into the research topics of 'Equivac® HeV vaccine for horses is cross protective against HeVg2 variant, as demonstrated by a recombinant Cedar Virus surrogate neutralisation assay.'. Together they form a unique fingerprint.

Cite this